This menu provides the list of EV miRNAs identified by high-throughput analyses.

Search:
Superdomain: All Prokaryote Eukaryote
Filter datasets:
  - "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
  - "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
Maximum false positive rate (FPR): Maximum true positive rate (TPR):
  - FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
  - TPR is the percentile of miRNA among the present miRNAs.
    Please see user manual in the contact us/help menu for detail.
Number of molecules in one page:

The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.

Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.

Mature name miRBase accession FPR TPR Publication Orthologous group Identification count
All / Prokaryote / Eukaryote
(FPR<0.05,TPR<0.5)
hsa-miR-371a-5pMIMAT0004687 0.0e+0 4.8e-1Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.		MIPF0000068_147 / 0 / 47
hsa-miR-371a-5pMIMAT0004687 0.0e+0 4.7e-1Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.		MIPF0000068_147 / 0 / 47
hsa-miR-371a-5pMIMAT0004687 1.1e-3 4.2e-1Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells.
Nat Commun. 2011;2:282. doi: 10.1038/ncomms1285.		MIPF0000068_147 / 0 / 47
hsa-miR-371a-5pMIMAT0004687 7.3e-3 4.4e-1Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells.
Nat Commun. 2011;2:282. doi: 10.1038/ncomms1285.		MIPF0000068_147 / 0 / 47
hsa-miR-371a-5pMIMAT0004687 4.3e-2 4.9e-1Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells.
Nat Commun. 2011;2:282. doi: 10.1038/ncomms1285.		MIPF0000068_147 / 0 / 47
hsa-miR-371a-5pMIMAT0004687 0.0e+0 3.7e-1Characterization of mRNA and microRNA in human mast cell-derived exosomes and their transfer to other mast cells and blood CD34 progenitor cells.
J Extracell Vesicles. 2012 Apr 16;1. doi: 10.3402/jev.v1i0.18389. eCollection 2012.		MIPF0000068_147 / 0 / 47
hsa-miR-371a-5pMIMAT0004687 0.0e+0 3.6e-1Characterization of mRNA and microRNA in human mast cell-derived exosomes and their transfer to other mast cells and blood CD34 progenitor cells.
J Extracell Vesicles. 2012 Apr 16;1. doi: 10.3402/jev.v1i0.18389. eCollection 2012.		MIPF0000068_147 / 0 / 47
hsa-miR-371a-5pMIMAT0004687 0.0e+0 3.7e-1Characterization of mRNA and microRNA in human mast cell-derived exosomes and their transfer to other mast cells and blood CD34 progenitor cells.
J Extracell Vesicles. 2012 Apr 16;1. doi: 10.3402/jev.v1i0.18389. eCollection 2012.		MIPF0000068_147 / 0 / 47
hsa-miR-371a-5pMIMAT0004687 0.0e+0 3.7e-1Characterization of mRNA and microRNA in human mast cell-derived exosomes and their transfer to other mast cells and blood CD34 progenitor cells.
J Extracell Vesicles. 2012 Apr 16;1. doi: 10.3402/jev.v1i0.18389. eCollection 2012.		MIPF0000068_147 / 0 / 47
hsa-miR-371a-5pMIMAT0004687 0.0e+0 3.4e-1Circulating exosomal microRNAs as biomarkers of colon cancer.
PLoS One. 2014 Apr 4;9(4):e92921. doi: 10.1371/journal.pone.0092921. eCollection 2014.		MIPF0000068_147 / 0 / 47
hsa-miR-371a-5pMIMAT0004687 0.0e+0 2.5e-2Circulating exosomal microRNAs as biomarkers of colon cancer.
PLoS One. 2014 Apr 4;9(4):e92921. doi: 10.1371/journal.pone.0092921. eCollection 2014.		MIPF0000068_147 / 0 / 47
hsa-miR-371a-5pMIMAT0004687 0.0e+0 1.1e-2The human miRNA repertoire of different blood compounds.
BMC Genomics. 2014 Jun 14;15:474. doi: 10.1186/1471-2164-15-474.		MIPF0000068_147 / 0 / 47
hsa-miR-371a-5pMIMAT0004687 0.0e+0 4.0e-2The human miRNA repertoire of different blood compounds.
BMC Genomics. 2014 Jun 14;15:474. doi: 10.1186/1471-2164-15-474.		MIPF0000068_147 / 0 / 47
hsa-miR-371a-5pMIMAT0004687 0.0e+0 3.4e-3The human miRNA repertoire of different blood compounds.
BMC Genomics. 2014 Jun 14;15:474. doi: 10.1186/1471-2164-15-474.		MIPF0000068_147 / 0 / 47
hsa-miR-371a-5pMIMAT0004687 0.0e+0 3.6e-1Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells.
Sci Signal. 2014 Jul 1;7(332):ra63. doi: 10.1126/scisignal.2005231.		MIPF0000068_147 / 0 / 47
hsa-miR-371b-5pMIMAT0019892 0.0e+0 3.7e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000068_147 / 0 / 47
hsa-miR-371b-5pMIMAT0019892 0.0e+0 2.9e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000068_147 / 0 / 47
hsa-miR-371a-5pMIMAT0004687 0.0e+0 3.8e-1Combined Evaluation of a Panel of Protein and miRNA Serum Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity.
Int J Cancer. 2014 Nov 12. doi: 10.1002/ijc.29324.		MIPF0000068_147 / 0 / 47
hsa-miR-371b-5pMIMAT0019892 0.0e+0 8.4e-2Combined Evaluation of a Panel of Protein and miRNA Serum Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity.
Int J Cancer. 2014 Nov 12. doi: 10.1002/ijc.29324.		MIPF0000068_147 / 0 / 47
hsa-miR-371b-5pMIMAT0019892 5.3e-13 2.6e-1Combined Evaluation of a Panel of Protein and miRNA Serum Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity.
Int J Cancer. 2014 Nov 12. doi: 10.1002/ijc.29324.		MIPF0000068_147 / 0 / 47
hsa-miR-371b-5pMIMAT0019892 1.7e-12 2.6e-1Combined Evaluation of a Panel of Protein and miRNA Serum Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity.
Int J Cancer. 2014 Nov 12. doi: 10.1002/ijc.29324.		MIPF0000068_147 / 0 / 47
hsa-miR-371a-5pMIMAT0004687 0.0e+0 4.4e-1Combined Evaluation of a Panel of Protein and miRNA Serum Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity.
Int J Cancer. 2014 Nov 12. doi: 10.1002/ijc.29324.		MIPF0000068_147 / 0 / 47
hsa-miR-371a-5pMIMAT0004687 0.0e+0 4.4e-1Combined Evaluation of a Panel of Protein and miRNA Serum Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity.
Int J Cancer. 2014 Nov 12. doi: 10.1002/ijc.29324.		MIPF0000068_147 / 0 / 47
hsa-miR-371a-5pMIMAT0004687 0.0e+0 1.1e-1Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000068_147 / 0 / 47
mmu-miR-294-5pMIMAT0004574 0.0e+0 3.6e-5Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000068_147 / 0 / 47
hsa-miR-371a-5pMIMAT0004687 0.0e+0 3.6e-2Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000068_147 / 0 / 47
mmu-miR-294-5pMIMAT0004574 0.0e+0 4.9e-5Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000068_147 / 0 / 47
hsa-miR-371a-5pMIMAT0004687 0.0e+0 6.6e-2Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000068_147 / 0 / 47
mmu-miR-294-5pMIMAT0004574 0.0e+0 9.7e-4Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000068_147 / 0 / 47
hsa-miR-371a-5pMIMAT0004687 0.0e+0 3.5e-3Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000068_147 / 0 / 47
mmu-miR-294-5pMIMAT0004574 0.0e+0 2.9e-2Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000068_147 / 0 / 47
hsa-miR-371a-5pMIMAT0004687 0.0e+0 4.3e-2Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000068_147 / 0 / 47
mmu-miR-294-5pMIMAT0004574 0.0e+0 4.7e-5Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000068_147 / 0 / 47
ppy-miR-371-5pMIMAT0015858 0.0e+0 5.7e-2Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000068_147 / 0 / 47
ppy-miR-371-5pMIMAT0015858 0.0e+0 3.9e-1Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000068_147 / 0 / 47
cfa-miR-371MIMAT0007747 0.0e+0 7.1e-2Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000068_147 / 0 / 47
ppy-miR-371-5pMIMAT0015858 0.0e+0 4.9e-4Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000068_147 / 0 / 47
cfa-miR-371MIMAT0007747 0.0e+0 1.8e-2Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000068_147 / 0 / 47
mmu-miR-295-5pMIMAT0004575 0.0e+0 2.0e-1Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000068_147 / 0 / 47
cfa-miR-371MIMAT0007747 0.0e+0 1.2e-1Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000068_147 / 0 / 47
ppy-miR-371-5pMIMAT0015858 0.0e+0 2.0e-4Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000068_147 / 0 / 47
mmu-miR-295-5pMIMAT0004575 0.0e+0 2.9e-1Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000068_147 / 0 / 47
ppy-miR-371-5pMIMAT0015858 0.0e+0 5.0e-1Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000068_147 / 0 / 47
cfa-miR-371MIMAT0007747 0.0e+0 1.3e-2Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000068_147 / 0 / 47
mmu-miR-290a-5pMIMAT0000366 0.0e+0 4.9e-1Influence of Erythropoietin on Microvesicles Derived from Mesenchymal Stem cells protecting renal function of Chronic Kidney disease.
Stem Cell Res Ther. 2015 May 22;6(1):100.		MIPF0000068_147 / 0 / 47
mmu-miR-290a-5pMIMAT0000366 0.0e+0 4.7e-1Influence of Erythropoietin on Microvesicles Derived from Mesenchymal Stem cells protecting renal function of Chronic Kidney disease.
Stem Cell Res Ther. 2015 May 22;6(1):100.		MIPF0000068_147 / 0 / 47
hsa-miR-371b-5pMIMAT0019892 0.0e+0 3.0e-2Diagnostic profiling of salivary exosomal microRNAs in oral lichen planus patients.
Oral Dis. 2015 Sep 21. doi: 10.1111/odi.12374.		MIPF0000068_147 / 0 / 47
hsa-miR-371b-5pMIMAT0019892 0.0e+0 8.1e-2Diagnostic profiling of salivary exosomal microRNAs in oral lichen planus patients.
Oral Dis. 2015 Sep 21. doi: 10.1111/odi.12374.		MIPF0000068_147 / 0 / 47
hsa-miR-371b-5pMIMAT0019892 2.2e-7 4.2e-1Extracellular vesicle miR-7977 is involved in hematopoietic dysfunction of mesenchymal stromal cells via poly(rC) binding protein 1 reduction in myeloid neoplasms.
Haematologica. 2016 Jan 22. pii: haematol.2015.134932.		MIPF0000068_147 / 0 / 47
hsa-miR-371a-5pMIMAT0004687 6.0e-6 4.6e-1Extracellular vesicle miR-7977 is involved in hematopoietic dysfunction of mesenchymal stromal cells via poly(rC) binding protein 1 reduction in myeloid neoplasms.
Haematologica. 2016 Jan 22. pii: haematol.2015.134932.		MIPF0000068_147 / 0 / 47
hsa-miR-371b-5pMIMAT0019892 4.0e-5 4.1e-1Extracellular vesicle miR-7977 is involved in hematopoietic dysfunction of mesenchymal stromal cells via poly(rC) binding protein 1 reduction in myeloid neoplasms.
Haematologica. 2016 Jan 22. pii: haematol.2015.134932.		MIPF0000068_147 / 0 / 47
hsa-miR-371a-5pMIMAT0004687 2.5e-4 4.5e-1Extracellular vesicle miR-7977 is involved in hematopoietic dysfunction of mesenchymal stromal cells via poly(rC) binding protein 1 reduction in myeloid neoplasms.
Haematologica. 2016 Jan 22. pii: haematol.2015.134932.		MIPF0000068_147 / 0 / 47
hsa-miR-371a-5pMIMAT0004687 0.0e+0 1.4e-1Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma.
Sci Rep. 2016 Dec 8;6:38750. doi: 10.1038/srep38750.		MIPF0000068_147 / 0 / 47
hsa-miR-371a-5pMIMAT0004687 0.0e+0 2.3e-1Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma.
Sci Rep. 2016 Dec 8;6:38750. doi: 10.1038/srep38750.		MIPF0000068_147 / 0 / 47
hsa-miR-371a-5pMIMAT0004687 0.0e+0 4.9e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000068_147 / 0 / 47
hsa-miR-371a-5pMIMAT0004687 0.0e+0 1.2e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000068_147 / 0 / 47
hsa-miR-371a-5pMIMAT0004687 0.0e+0 2.0e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000068_147 / 0 / 47
hsa-miR-371a-5pMIMAT0004687 0.0e+0 2.3e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000068_147 / 0 / 47
hsa-miR-371b-5pMIMAT0019892 0.0e+0 3.5e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000068_147 / 0 / 47
hsa-miR-371b-5pMIMAT0019892 0.0e+0 3.5e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000068_147 / 0 / 47
hsa-miR-371a-5pMIMAT0004687 0.0e+0 2.0e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000068_147 / 0 / 47
hsa-miR-371a-5pMIMAT0004687 0.0e+0 2.8e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000068_147 / 0 / 47
hsa-miR-371a-5pMIMAT0004687 0.0e+0 2.8e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000068_147 / 0 / 47
hsa-miR-371b-5pMIMAT0019892 0.0e+0 3.3e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000068_147 / 0 / 47
hsa-miR-371b-5pMIMAT0019892 0.0e+0 3.1e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000068_147 / 0 / 47
mmu-miR-290a-5pMIMAT0000366 0.0e+0 8.7e-2Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		MIPF0000068_147 / 0 / 47
mmu-miR-290a-5pMIMAT0000366 0.0e+0 5.0e-7Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		MIPF0000068_147 / 0 / 47
mmu-miR-291a-5pMIMAT0000367 0.0e+0 3.1e-6Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		MIPF0000068_147 / 0 / 47
mmu-miR-292a-5pMIMAT0000369 0.0e+0 1.3e-4Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		MIPF0000068_147 / 0 / 47
mmu-miR-293-5pMIMAT0004573 0.0e+0 4.1e-1Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		MIPF0000068_147 / 0 / 47
mmu-miR-294-5pMIMAT0004574 0.0e+0 2.5e-3Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		MIPF0000068_147 / 0 / 47
mmu-miR-295-5pMIMAT0004575 0.0e+0 3.9e-3Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		MIPF0000068_147 / 0 / 47
hsa-miR-371a-5pMIMAT0004687 0.0e+0 4.9e-1Tumor microenvironment interruption: a novel anti-cancer mechanism of Proton-pump inhibitor in gastric cancer by suppressing the release of microRNA-carrying exosomes.
Am J Cancer Res. 2017 Sep 1;7(9):1913-1925. eCollection 2017.		MIPF0000068_147 / 0 / 47
hsa-miR-371b-5pMIMAT0019892 0.0e+0 4.1e-1Tumor microenvironment interruption: a novel anti-cancer mechanism of Proton-pump inhibitor in gastric cancer by suppressing the release of microRNA-carrying exosomes.
Am J Cancer Res. 2017 Sep 1;7(9):1913-1925. eCollection 2017.		MIPF0000068_147 / 0 / 47
hsa-miR-371b-5pMIMAT0019892 0.0e+0 4.1e-1Tumor microenvironment interruption: a novel anti-cancer mechanism of Proton-pump inhibitor in gastric cancer by suppressing the release of microRNA-carrying exosomes.
Am J Cancer Res. 2017 Sep 1;7(9):1913-1925. eCollection 2017.		MIPF0000068_147 / 0 / 47
hsa-miR-371a-5pMIMAT0004687 0.0e+0 4.6e-1Tumor microenvironment interruption: a novel anti-cancer mechanism of Proton-pump inhibitor in gastric cancer by suppressing the release of microRNA-carrying exosomes.
Am J Cancer Res. 2017 Sep 1;7(9):1913-1925. eCollection 2017.		MIPF0000068_147 / 0 / 47
hsa-miR-371b-5pMIMAT0019892 0.0e+0 2.9e-1Tumor microenvironment interruption: a novel anti-cancer mechanism of Proton-pump inhibitor in gastric cancer by suppressing the release of microRNA-carrying exosomes.
Am J Cancer Res. 2017 Sep 1;7(9):1913-1925. eCollection 2017.		MIPF0000068_147 / 0 / 47
hsa-miR-371b-5pMIMAT0019892 0.0e+0 2.8e-1Tumor microenvironment interruption: a novel anti-cancer mechanism of Proton-pump inhibitor in gastric cancer by suppressing the release of microRNA-carrying exosomes.
Am J Cancer Res. 2017 Sep 1;7(9):1913-1925. eCollection 2017.		MIPF0000068_147 / 0 / 47
hsa-miR-371a-5pMIMAT0004687 0.0e+0 7.4e-3Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.		MIPF0000068_147 / 0 / 47
hsa-miR-371b-5pMIMAT0019892 0.0e+0 3.2e-3Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.		MIPF0000068_147 / 0 / 47
hsa-miR-371a-5pMIMAT0004687 0.0e+0 1.3e-1Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.		MIPF0000068_147 / 0 / 47
hsa-miR-371b-5pMIMAT0019892 0.0e+0 9.7e-2Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.		MIPF0000068_147 / 0 / 47
hsa-miR-371b-5pMIMAT0019892 3.4e-4 3.4e-4Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.		MIPF0000068_147 / 0 / 47
hsa-miR-371a-5pMIMAT0004687 5.7e-3 5.7e-3Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.		MIPF0000068_147 / 0 / 47
hsa-miR-371b-5pMIMAT0019892 6.5e-4 6.5e-4Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.		MIPF0000068_147 / 0 / 47
hsa-miR-371a-5pMIMAT0004687 4.1e-3 4.1e-3Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.		MIPF0000068_147 / 0 / 47
[1]